AONs can be designed against splice sites or enhancer elements to induce exon skipping in cells of DMD patients, and have shown restoration of the reading frame of dystrophin 28 days after intramuscular injection of AON into the tibialis anterior muscle [16]. Here, DMD is linked to Duchenne muscular dystrophy.